These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12558771)

  • 1. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Silberstein SD; McCrory DC
    Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serotonin agonists and antagonists in migraine].
    Ollat H
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
    Tfelt-Hansen PC; Koehler PJ
    Cephalalgia; 2008 Aug; 28(8):877-86. PubMed ID: 18460007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648
    [No Abstract]   [Full Text] [Related]  

  • 6. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine: pathophysiology, pharmacology, treatment and future trends.
    Villalón CM; Centurión D; Valdivia LF; de Vries P; Saxena PR
    Curr Vasc Pharmacol; 2003 Mar; 1(1):71-84. PubMed ID: 15320857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.
    Glusa E; Roos A
    Br J Pharmacol; 1996 Sep; 119(2):330-4. PubMed ID: 8886417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Van Mil JW
    Ned Tijdschr Geneeskd; 1993 Jun; 137(24):1213-4. PubMed ID: 8391659
    [No Abstract]   [Full Text] [Related]  

  • 11. The 5-HT
    Whealy M; Becker WJ
    Handb Clin Neurol; 2024; 199():17-42. PubMed ID: 38307644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of the acute migraine attack].
    Titus F
    Rev Neurol; 1995; 23 Suppl 2():S203-7. PubMed ID: 7497289
    [No Abstract]   [Full Text] [Related]  

  • 13. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
    Dahlöf C; Maassen Van Den Brink A
    Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine-2A receptors in the isolated rat aorta.
    Kalkman HO; Schneider F
    Pharmacology; 1996 Dec; 53(6):351-5. PubMed ID: 9032799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
    den Boer MO; Heiligers JP; Saxena PR
    Br J Pharmacol; 1991 Sep; 104(1):183-9. PubMed ID: 1664762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.
    Brown AM; Patch TL; Kaumann AJ
    Br J Pharmacol; 1991 Sep; 104(1):45-8. PubMed ID: 1786517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
    Deliganis AV; Peroutka SJ
    Headache; 1991 Apr; 31(4):228-31. PubMed ID: 1646776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ergotamine and dihydroergotamine: a review.
    Bigal ME; Tepper SJ
    Curr Pain Headache Rep; 2003 Feb; 7(1):55-62. PubMed ID: 12525272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
    den Boer MO; Somers JA; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):577-83. PubMed ID: 1330188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimigraine drugs.
    Diener HC; Kaube H; Limmroth V
    J Neurol; 1999 Jul; 246(7):515-9. PubMed ID: 10463349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.